Intellipharmaceutics International, Inc. (IPCIQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Intellipharmaceutics International Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 1.443M |
| October 02, 2026 | 1.443M |
| October 01, 2026 | 1.443M |
| September 30, 2026 | 1.443M |
| September 29, 2026 | 1.443M |
| September 28, 2026 | 1.443M |
| September 25, 2026 | 1.443M |
| September 24, 2026 | 1.443M |
| September 23, 2026 | 1.443M |
| September 22, 2026 | 1.443M |
| September 21, 2026 | 1.443M |
| September 18, 2026 | 1.443M |
| September 17, 2026 | 1.443M |
| September 16, 2026 | 1.443M |
| September 15, 2026 | 1.443M |
| September 14, 2026 | 1.443M |
| September 11, 2026 | 1.443M |
| September 10, 2026 | 1.443M |
| September 09, 2026 | 1.443M |
| September 08, 2026 | 1.443M |
| September 04, 2026 | 1.443M |
| September 03, 2026 | 1.443M |
| September 02, 2026 | 1.443M |
| September 01, 2026 | 1.443M |
| August 31, 2026 | 1.443M |
| Date | Value |
|---|---|
| August 28, 2026 | 1.443M |
| August 27, 2026 | 1.443M |
| August 26, 2026 | 1.443M |
| August 25, 2026 | 1.443M |
| August 24, 2026 | 1.443M |
| August 21, 2026 | 1.443M |
| August 20, 2026 | 1.443M |
| August 19, 2026 | 1.443M |
| August 18, 2026 | 1.443M |
| August 17, 2026 | 1.443M |
| August 14, 2026 | 1.443M |
| August 13, 2026 | 1.443M |
| August 12, 2026 | 1.443M |
| August 11, 2026 | 1.443M |
| August 10, 2026 | 1.443M |
| August 07, 2026 | 1.443M |
| August 06, 2026 | 1.443M |
| August 05, 2026 | 1.443M |
| August 04, 2026 | 1.443M |
| August 03, 2026 | 1.443M |
| July 31, 2026 | 1.443M |
| July 30, 2026 | 1.443M |
| July 29, 2026 | 1.443M |
| July 28, 2026 | 1.443M |
| July 27, 2026 | 1.443M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abattis Bioceuticals Corp. | -- |
| InMed Pharmaceuticals, Inc. | 4.867M |
| Tetra Bio-Pharma, Inc. | -- |
| NervGen Pharma Corp. | 131.43M |
| Milestone Pharmaceuticals, Inc. | 68.26M |